Clean Food Group: £4.5 Million Investment Led by Clean Growth Fund and New Agrarian

Funding to accelerate scale-up of world-leading Knowsley fermentation facility LONDON–(BUSINESS WIRE)–Clean Food Group, a leading UK biotech manufacturer pioneering sustainable oils and fats through fermentation, is pleased to confirm a £4.5 million investment led by Clean Growth Fund and New Agrarian, two specialist investors dedicated to fostering sustainable growth in food technology. CFG has also … [Read more…]

Anthem Blue Cross and Blue Shield and Mount Sinai Health System Reach New Multi-Year Agreement

NEW YORK–(BUSINESS WIRE)–Anthem Blue Cross and Blue Shield in New York today announced a new three-year agreement with Mount Sinai Health System that returns its hospitals, physicians, and other care providers to Anthem’s network. The agreement keeps Mount Sinai care accessible for Anthem members and reflects both organizations’ commitment to delivering quality care while helping … [Read more…]

Protests: AHF Blasts Gilead Over Extortionate AIDS Drug Pricing

Daily April 14-17, Gilead HQ, 10:30 a.m. -11:30 a.m. HIV drug maker’s pricing for its lifesaving HIV drugs puts nation’s HIV safety nets under tremendous strain; one Gilead’s HIV medication, Biktarvy, carried an annual sticker price of nearly $61,000 per patient in 2025 SAN FRANCISCO–(BUSINESS WIRE)–#AHFcares–Advocates and mobilizers affiliated with AIDS Healthcare Foundation (AHF) will … [Read more…]

Travere Therapeutics Announces Full FDA Approval of FILSPARI® (sparsentan), the First and Only Approved Medicine for FSGS

FILSPARI indicated to reduce proteinuria in adults and children aged 8 years and older with FSGS who do not have nephrotic syndrome Additional indication for FILSPARI expands total addressable population to more than 100,000 patients in the U.S, including more than 30,000 patients with FSGS Label aligns with KDIGO clinical practice guidelines for managing patients … [Read more…]

NomosLogic Introduces Molecular Medicine Infrastructure for Consumer Genomics, Multi-Omic Fusion, and Deterministic Disease Modeling

SALT LAKE CITY–(BUSINESS WIRE)–NomosLogic, Inc. today introduced its molecular medicine infrastructure platform, designed to transform raw genomic files into clinically actionable intelligence across pharmacogenomics, disease susceptibility, and systems-level health modeling. NomosLogic operates as an infrastructure layer for molecular medicine rather than a point product. Its integrated stack includes: TRINITY, a deterministic multi-omic fusion engine for … [Read more…]

Belmont Village Senior Living Leaders Honored with 2026 TALA Hero Award for Senior Care Excellence

Candice Stoner and Courtney Mueller join a decade-long legacy of TALA Hero Award recognition HOUSTON–(BUSINESS WIRE)–Belmont Village Senior Living proudly announces Candice Stoner, Executive Director at Belmont Village West Lake Hills and Courtney Mueller, Memory Program Director at Belmont Village West University, have been recognized with the prestigious Texas Assisted Living Association (TALA) Hero Award. … [Read more…]

Genmab Presents the Safety and Tolerability of Rinatabart Sesutecan (Rina-S®) in Combination with Bevacizumab in Advanced Ovarian Cancer

Phase 1/2 RAINFOL™-01 data showed the combination of rinatabart sesutecan (Rina-S®) and bevacizumab was tolerable, with no new safety signals in patients with advanced ovarian cancer The ongoing Phase 3 RAINFOL-04 trial will further evaluate the combination in patients with recurrent platinum-sensitive ovarian cancer (PSOC) COPENHAGEN, Denmark–(BUSINESS WIRE)–Genmab A/S (Nasdaq: GMAB) announced today new data … [Read more…]

Prodalim Expands Solos Technology Platform in the United States with New California Operations

WINTER GARDEN, Fla.–(BUSINESS WIRE)–Prodalim, a global leader in juice and specialty ingredients solutions, announced today the expansion of its Solos platform in the United States with the launch of operations at a new facility in Hopland, California. The new site marks a key milestone in the continued globalization of Solos, Prodalim’s patented aroma recovery and … [Read more…]

Almirall and Barcelona Supercomputing Center Expand Their Collaboration to Accelerate Innovation in Medical Dermatology

The strategic framework agreement deepens the long-standing partnership, leveraging Artificial Intelligence and High-Performance Computing to identify new opportunities of collaboration in the discovery of new therapies for skin diseases. Almirall joins the ‘BSC Connects’ program to foster public-private collaboration and enhance its R&D capabilities. The alliance strengthens Almirall’s innovation strategy by integrating disruptive technologies to … [Read more…]

Number of Shares and Voting Rights of Innate Pharma as of April 9, 2026

MARSEILLE, France–(BUSINESS WIRE)–Regulatory News: Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or “AMF”) General Regulation, Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) releases its total number of shares outstanding as well … [Read more…]